Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-645P is a non-protein-coding pseudogene classified as part of the U6 small nuclear RNA pseudogene family. U6 snRNAs are highly conserved RNAs critical for spliceosome function and pre-mRNA splicing. However, pseudogenes like RNU6-645P do not encode functional snRNA. Most pseudogenes in the U6 family serve no direct known function but may play roles in genome evolution or regulation by acting as competitive endogenous RNAs in some cases. RNU6-645P specifically is annotated in genome databases but has no established biological activity or role in disease. RNU6-645P is a correctly named human pseudogene, not a therapeutic target or major disease marker, with no known biological or clinical function and no associated drugs or safety concerns. Its presence is mainly as a genomic annotation with potential indirect regulatory effects that remain unstudied for this specific pseudogene.
None known, as it is not a therapeutic target
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 645, pseudogene (RNU6-645P).